ENANTA PHARMACEUTICALS, INC (ENTA) Operating margin 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) operating margin by fiscal year — reported operating income divided by reported revenue.
-130.7%FY2025 · since FY2017: 23.9% → -130.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -130.7% | +49.3 pp |
| FY2024 | -179.9% | -6.7 pp |
| FY2023 | -173.2% | -29.5 pp |
| FY2022 | -143.7% | -30.9 pp |
| FY2021 | -112.9% | -78.9 pp |
| FY2020 | -34.0% | -51.9 pp |
| FY2019 | 17.9% | -24.8 pp |
| FY2018 | 42.7% | +18.8 pp |
| FY2017 | 23.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice